Jim Cramer Backs CME Group and Cboe as Exchange Duopoly Plays
Cramer spotlights CME and Cboe as dominant exchange operators worth watching. Here's the tradeable case for both.
Jim Cramer is putting his stamp of approval on two names that quietly run the show in derivatives trading: CME Group and Cboe Global Markets. These aren't flashy momentum stocks — they're the toll-road operators of Wall Street, and Cramer thinks that's exactly the point.
CME and Cboe together form what amounts to a duopoly over futures and options markets in the U.S. When volatility spikes and traders rush to hedge, both exchanges collect fees on every contract that changes hands. Volume goes up, revenue follows — it's a remarkably durable business model that doesn't depend on picking winners in the market.
Read more SpaceX Takeover Could Unlock Musk's Blocked Tesla Pay Deal →
For retail traders, the appeal here is straightforward. You don't have to be right about where stocks go. You just have to believe that people will keep trading options and futures — and given the explosion of retail derivatives activity in recent years, that's not a hard bet to make. These companies profit from participation, not direction.
Cramer's endorsement fits a broader pattern of favoring infrastructure-style financial names over pure speculation. Exchanges carry pricing power, high margins, and meaningful barriers to entry. A new competitor can't just show up and displace CME's grip on interest-rate futures or Cboe's dominance in equity options overnight.
If you're looking for financial-sector exposure that isn't pure bank risk and doesn't live or die by the Fed's next move, CME and Cboe deserve a spot on your radar. Continue reading at Yahoo Finance.
